Levels of Homotypic Neutralizing Antibody in Human Poliomyelitis Three Years after Infection
نویسندگان
چکیده
Quantitative neutralization tests in monkeys were carried out on sera obtained from 7 patients, 3 months, and 3 years after an attack of poliomyelitis. The serum specimens were tested against 100 to 1000 PD(50) of the patient's own strain of virus, recovered during the acute phase of the illness; all the strains were Type 1. The 6 patients, aged 6 months to 13 years, who had a paralytic attack of the disease, all exhibited very high levels of neutralizing antibody at 3 years as well as at 3 months after onset. The 50 per cent serum dilution titers ranged from about 1:180 to at least 1:860. Since the maximum titers were not established, it is not known to what extent, if any, the level of antibody may have dropped over the 3 year period. One of the patients, with a diagnosis of non-paralytic poliomyelitis, had a negligible or questionable antibody response during convalescence and no demonstrable antibody at 3 years; there is justifiable doubt as to whether the Type 1 poliomyelitis virus recovered from this patient had actually caused infection. Tests for Lansing neutralizing antibody indicated that the 5 patients who had no evidence of previous infection with Type 2 poliomyelitis virus had not become infected with it during the 3 year period. This suggested that these patients did not live in an environment in which infection with poliomyelitis virus is frequent. It is concluded, therefore, that in human beings, paralytic infections due to Type 1 poliomyelitis virus produce large amounts of homotypic neutralizing antibody, which persists at high levels for a period of at least 3 years.
منابع مشابه
Levels of Homotypic Neutralizing Antibody in Human Poliomyelitis T H R E E Years after Infection* by Johan
I t has been demonstrated that patients with poliomyelitis, as a rule, have neutralizing antibody for the infecting strain of virus early after onset of first symptoms before the appearance of paralysis, and that this antibody increases in titer during convalescence (1, 2). For a better understanding of human immunity to poliomyelitis and of the part immune individuals may play in the dissemina...
متن کاملHomotypic Complement-fixing Antibody in Monkeys Infected with Type 2 Poliomyelitis Virus by the Oral Route
CF tests with Type 2 poliomyelitis antigen (MEF1) were performed on the pre- and postinfection sera of 20 cynomolgus monkeys which developed paralytic, non-paralytic, or inapparent infection following oral administration of a Type 2 strain of virus (Y-SK). All the monkeys developed neutralizing antibody, and 17 developed CF antibody in an original serum dilution titer of 1:4 or greater. The 3 m...
متن کاملTransitory Appearance of Type 2 Neutralizing Antibody in Patients Infected with Type 1 Poliomyelitis Virus
Neutralizing antibodies for Type 2 (Lansing) poliomyelitis virus were tested periodically in a group of 18 patients from whom Type 1 poliomyelitis virus was recovered. Data for homotypic neutralizing antibodies and Type 2 complement-fixing antibodies were also available on the majority of these patients. The results indicated that Type 2 neutralizing antibodies first appeared or significantly i...
متن کاملPoliomyelitis Vaccine
The Epidemiology of poliomgelitis has been investigated in our country Pasteur Institute; the incidence of Poliomgelitis, after the age of 4 years i's rare, in Iran. Passive antibody of maternal origin do not interfere with production of active antibody after immunization. Inactivated Polio Vaccine (salk) has been effective in reducing the incidence of poliomgelitis by approximately 90 per ...
متن کاملPoliovirus neutralization test with poliovirus pseudovirus to measure neutralizing antibody in humans.
We complement Arita et al. (1) for their development of a safe, simple, and rapid test, employing poliovirus pseudovirus (generating luciferase signals) instead of the wild poliovirus, to measure the poliovirus neutralizing antibody titer in human serum. Apart from the end game of the global poliomyelitis eradication program, poliovirus pseudovirus technology (1) would be advantageous in the su...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of Experimental Medicine
دوره 96 شماره
صفحات -
تاریخ انتشار 1952